RXRB Human Pre-designed siRNA Set A contains three designed siRNAs for RXRB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

RXRG Human Pre-designed siRNA Set A contains three designed siRNAs for RXRG gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Rxrg Mouse Pre-designed siRNA Set A contains three designed siRNAs for Rxrg gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

RXRG Rat Pre-designed siRNA Set A contains three designed siRNAs for RXRG gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

RYBP Human Pre-designed siRNA Set A contains three designed siRNAs for RYBP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

RYK Human Pre-designed siRNA Set A contains three designed siRNAs for RYK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

RYR1 Human Pre-designed siRNA Set A contains three designed siRNAs for RYR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

RYR2 Human Pre-designed siRNA Set A contains three designed siRNAs for RYR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

RYR3 Human Pre-designed siRNA Set A contains three designed siRNAs for RYR3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

S-(2-Furanylmethyl) methanethioate-d2 is deuterated labeled S-(2-Furanylmethyl) methanethioate.

S-(3-Hydroxydodecanoate)-CoACoenzyme A, a Coenzyme A, is a metabolite that can be found or produced in E. coli (strain K12, MG1655)[1].

S-5751 is an orally active prostaglandin DP receptor antagonist. S-5751 inhibits cAMP generation in platelet-rich plasma induced by PGD2 with IC50 0.12 μM. S-5751 has anti-inflammatory activity. S-5751 can be used in asthma research[1].

S-NEPC (4-Nitrophenyl-2S,3S-epoxy-3 phenylpropyl carbonate) is a colorimetric substrate used to measure epoxide hydrolase activity[1].

S-Phenyl-d5-mercapturic Acid is deuterated labeled S-Phenyl.

S-Phenylsulfonylcysteine is a reagent for blocking thiol (-SH) groups on proteins and peptides[1].

S-Thanatin is an insect antimicrobial peptide with potent broad-spectrum antibacterial activity. S-Thanatin can inhibit the activity of Gram-negative bacteria, Gram-positive bacteria, and fungi, without cytotoxicity. The antibacterial activity of S-Thanatin is not affected by PH value, but monovalent cations (Na+/K+) can reduce its antibacterial activity against Gram-negative bacteria in a dose-dependent manner[1].

S100A1 Human Pre-designed siRNA Set A contains three designed siRNAs for S100A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

S100A10 Human Pre-designed siRNA Set A contains three designed siRNAs for S100A10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

S100A11 Human Pre-designed siRNA Set A contains three designed siRNAs for S100A11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

S100A12 Human Pre-designed siRNA Set A contains three designed siRNAs for S100A12 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

S100A13 Human Pre-designed siRNA Set A contains three designed siRNAs for S100A13 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

S100A14 Human Pre-designed siRNA Set A contains three designed siRNAs for S100A14 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

S100A16 Human Pre-designed siRNA Set A contains three designed siRNAs for S100A16 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

S100A2 Human Pre-designed siRNA Set A contains three designed siRNAs for S100A2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

S100A3 Human Pre-designed siRNA Set A contains three designed siRNAs for S100A3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

S100A4 Human Pre-designed siRNA Set A contains three designed siRNAs for S100A4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

S100A5 Human Pre-designed siRNA Set A contains three designed siRNAs for S100A5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

S100A6 Human Pre-designed siRNA Set A contains three designed siRNAs for S100A6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

S100A7 Human Pre-designed siRNA Set A contains three designed siRNAs for S100A7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

S100A7A Human Pre-designed siRNA Set A contains three designed siRNAs for S100A7A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

S100A8 Human Pre-designed siRNA Set A contains three designed siRNAs for S100A8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

S100A9 Human Pre-designed siRNA Set A contains three designed siRNAs for S100A9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

S100B Human Pre-designed siRNA Set A contains three designed siRNAs for S100B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

S100G Human Pre-designed siRNA Set A contains three designed siRNAs for S100G gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

S100P Human Pre-designed siRNA Set A contains three designed siRNAs for S100P gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

S100Z Human Pre-designed siRNA Set A contains three designed siRNAs for S100Z gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

S16–1029 is a selective and orally active butyrylcholinesterase (BChE) inhibitor with IC50s of 11.35 nM and 48.1 nM for eqBChE and hBChE, respectively. S16–1029 could cross the blood-brain barrier (BBB) and reach the central nervous system (CNS). S16–1029 can be used for Alzheimer’s disease (AD) research[1].

S1PR1 Human Pre-designed siRNA Set A contains three designed siRNAs for S1PR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

S1pr1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for S1pr1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

S1pr1 Rat Pre-designed siRNA Set A contains three designed siRNAs for S1pr1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

S1PR2 Human Pre-designed siRNA Set A contains three designed siRNAs for S1PR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

S1pr2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for S1pr2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

S1pr2 Rat Pre-designed siRNA Set A contains three designed siRNAs for S1pr2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.